Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1076

1.

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.

American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O'Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT.

J Clin Oncol. 2006 Aug 1;24(22):3693-704. Epub 2006 Jul 10. Review.

PMID:
16832122
2.

Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.

Lefebvre JL, Ang KK; Larynx Preservation Consensus Panel.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1293-303. doi: 10.1016/j.ijrobp.2008.10.047.

PMID:
19306746
3.

Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.

Lefebvre JL, Ang KK; Larynx Preservation Consensus Panel.

Head Neck. 2009 Apr;31(4):429-41. doi: 10.1002/hed.21081.

PMID:
19283793
4.

What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients.

Alterio D, Ansarin M, Jereczek-Fossa BA, Zorzi S, Santoro L, Zerini D, Massaro M, Rondi E, Ferrario S, Piperno G, Cossu Rocca M, Griseri M, Preda L, Chiesa F, Orecchia R.

Tumori. 2013 Nov-Dec;99(6):667-75. doi: 10.1700/1390.15454.

PMID:
24503789
5.

Larynx preservation clinical trial design: summary of key recommendations of a consensus panel.

Ang KK.

Oncologist. 2010;15 Suppl 3:25-9. doi: 10.1634/theoncologist.2010-S3-25.

6.

Larynx preservation and survival trends: should there be concern?

Forastiere AA.

Head Neck. 2010 Jan;32(1):14-7. doi: 10.1002/hed.21295. No abstract available.

PMID:
19953631
7.

Multidisciplinary management controversies in laryngeal cancer.

Goh C, O'Sullivan B, Warde P, Groome P, Gullane P.

Ann Acad Med Singapore. 1996 May;25(3):405-12. Review.

PMID:
8876908
8.

Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.

Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.

Laryngoscope. 2006 Sep;116(9):1651-6.

PMID:
16954998
9.

Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.

Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M, Esclamado RM, Lavertu P, Carroll MA.

Head Neck. 2008 Dec;30(12):1535-42. doi: 10.1002/hed.20902.

PMID:
18704968
10.

[Surgical management of laryngeal cancer and preservation of laryngeal function].

Zhang L, Luan X, Pan X, Xie G, Xu F, Liu D, Lei D.

Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1461-3. Chinese.

PMID:
12509906
11.

Organ preservation for advanced laryngeal carcinoma.

Foote RL, Foote RT, Brown PD, Garces YI, Okuno SH, Strome SE.

Head Neck. 2006 Aug;28(8):689-96. Erratum in: Head Neck. 2007 Jan;29(1):87.

PMID:
16619278
12.

[Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].

Zhang DG, Zhang HB, Luan XY, Pan XL, Xie G.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):379-81. Chinese.

PMID:
17892137
13.

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, Taplin M, Vogelzang NJ, Wade JL 3rd, Bennett CL, Scher HI; American Society of Clinical Oncology.

J Clin Oncol. 2007 Apr 20;25(12):1596-605. Epub 2007 Apr 2. Review.

PMID:
17404365
14.

[Organ preservation in ORL oncology: myth or reality. The case for laryngeal preservation].

Eschwège F, Bourhis J, Luboinski B, Lefebvre JL.

Cancer Radiother. 1998 Sep-Oct;2(5):437-45. Review. French.

PMID:
9868386
15.

Organ preservation therapy for advanced-stage laryngeal carcinoma.

Hoffman HT, McCulloch T, Gustin D, Karnell LH.

Otolaryngol Clin North Am. 1997 Feb;30(1):113-30. Review.

PMID:
8995140
16.

Horizontovertical laryngectomy for supraglottic carcinoma.

Tu GY, Tang PZ, Jia CY.

Otolaryngol Head Neck Surg. 1997 Sep;117(3 Pt 1):280-6.

PMID:
9334778
17.

Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.

Wolf GT, Bradford CR, Urba S, Smith A, Eisbruch A, Chepeha DB, Teknos TN, Worden F, Dawson L, Terrell JE, Hogikyan ND.

Laryngoscope. 2002 Aug;112(8 Pt 1):1351-6.

PMID:
12172244
18.

Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines.

Gillison ML, Forastiere AA.

Hematol Oncol Clin North Am. 1999 Aug;13(4):699-718, vi. Review.

PMID:
10494508
19.

Current status of larynx preservation trials.

Lefebvre JL, Bonneterre J.

Curr Opin Oncol. 1996 May;8(3):209-14. Review.

PMID:
8794149
20.

[Surgical management of aged patients with hypopharyngeal carcinoma and preservation of laryngeal function].

Zhang DG, Luan XY, Pan XL, Xie G.

Ai Zheng. 2005 Nov;24(11):1372-5. Chinese.

PMID:
16552966

Supplemental Content

Support Center